NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD - No Study Results Posted - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD

This study has been completed.

Study NCT00557011 Information provided by New River Pharmaceuticals

First Received: November 9, 2007 Last Updated: May 23, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	December 2004
Estimated Primary Completion Date:	No date given

Publications:

Biederman J, Boellner SW, Childress A, Lopez FA, Krishnan S, Zhang Y. Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts Extended-Release in Children with ADHD: A Double-Blind, Placebo-Controlled, Crossover Analog Classroom Study. Biol Psychiatry. 2007 Nov 1;62(9):970-6. Epub 2007 Jul 12.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Faraone SV, Spencer TJ, Kollins SH, Glatt SJ. Effects of lisdexamfetamine dimesylate treatment for ADHD on growth. J Am Acad Child Adolesc Psychiatry. 2010 Jan;49(1):24-32.

Back to top of Main Content